| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.06 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |